loading page

Successful treatment of IgG4-related hypertrophic pachymeningitis with induction rituximab and dexamethasone followed by maintenance rituximab
  • +5
  • Karan Seegobin,
  • Muhamad Alhaj Moustafa,
  • Nicole Gannon,
  • Katelyn Keller,
  • Jacquelyn Hastings,
  • Vivek Gupta,
  • Han W. Tun,
  • Liuyan Jiang
Karan Seegobin
Mayo Clinic Hospital Jacksonville
Author Profile
Muhamad Alhaj Moustafa
Mayo Clinic's Campus in Florida, Mayo Clinic
Author Profile
Nicole Gannon
Mayo Clinic's Campus in Florida
Author Profile
Katelyn Keller
Mayo Clinic Hospital Jacksonville
Author Profile
Jacquelyn Hastings
Mayo Clinic Hospital Jacksonville
Author Profile
Vivek Gupta
Mayo Clinic Hospital Jacksonville
Author Profile
Han W. Tun
Mayo Clinic Hospital Jacksonville
Author Profile
Liuyan Jiang
Mayo Clinic Hospital Jacksonville
Author Profile

Abstract

IgG4-related disease (IgG4RD) with intracranial involvement is rare. We report a 56-year-old male who had an excellent response to rituximab and dexamethasone after going undiagnosed for 5 years. After 3 years of rituximab maintenance, he has no evidence of disease on brain MRI.

Peer review status:ACCEPTED

04 Sep 2020Submitted to Clinical Case Reports
07 Sep 2020Submission Checks Completed
07 Sep 2020Assigned to Editor
20 Sep 2020Reviewer(s) Assigned
09 Dec 2020Review(s) Completed, Editorial Evaluation Pending
09 Dec 2020Editorial Decision: Revise Minor
01 Jan 20211st Revision Received
04 Jan 2021Submission Checks Completed
04 Jan 2021Assigned to Editor
04 Jan 2021Review(s) Completed, Editorial Evaluation Pending
05 Jan 2021Reviewer(s) Assigned
09 Jan 2021Editorial Decision: Accept